TOTAL VOLUME:

$134.2b

24H VOL:

$134,145,987

24H TRANSACTIONS:

2,388,728,490

OPEN INTEREST:

$1,441,166,947

406,422

Markets across

30,383

events

MATCHED EVENTS:

2,688

PLATFORM COVERAGE:

5

Polymarket:

39%

VS.

Kalshi:

61%

BETA
Dashboards
Tour
All
Measles cases in U.S. in 2026?
polymarket
kalshi

Measles cases in U.S. in 2026?

Total volume:
$9,406,849
Volume 24h:
$2,739
66%
Liquidity:
$24,182
23%
Open interest:
$357,137
0.01%

Above 3000

all

2 markets

Kalshi

Polymarket

consensus

News

Positive

Negative

Neutral

Hover marker for details

Vol.

·

Resolves Jan 1, 2027

Will there be more than 3000 measles cases in 2026?

99%chance
Amount

$

Trade on
kalshi

Trade on Kalshi

Join Kalshi and score $25 for your first trade.At 100¢ buys you 100 shares | Odds: 99% Total Payout: $100 | Net Profit: $0 Multiplier: 1.00x | ROI: 0% | APY: 0% Illiquid market 92 days to resolution
You will be redirected to the platform to complete this trade.
Outcome
Trade
Chance %
Price
Spread
Liquidity
Volume
24h
7d
Open Interest
Ends in
Result
kalshi

Above 3000

Trade
99%
Yes 100¢No 1¢
1¢
N/A
$80,209
0%
10%
$26,118
3mo 2d
active
polymarket

↑3k

100%
Yes 100¢No 0.1¢
0.1¢
N/A
$94,190
N/A
N/A
N/A
3mo 3d
Yes
PredictionHero
Market Consensus
99.5%
Yes 100¢No 0.6¢
Avg: 0.6¢Max: 1¢
polymarket

↑4k

98%
Yes 99.2¢No 2.8¢
2¢
$3,597
$242,966
0%
0.68%
N/A
3mo 3d
active
kalshi

Above 4000

97%
Yes 99¢No 2¢
1¢
N/A
$424,887
0%
4%
$80,647
3mo 2d
active
PredictionHero
Market Consensus
97.5%
Yes 99.1¢No 2.4¢
Avg: 1.5¢Max: 2¢
polymarket

↑4.5k

94%
Yes 95.8¢No 6.9¢
2.7¢
$1,773
$4,580
0%
4%
N/A
3mo 3d
active
polymarket

↑4.75k

93%
1%
Yes 94.5¢No 8.9¢
3.4¢
$628
$64,676
0.04%
0.98%
N/A
3mo 3d
active
polymarket

↑5k

87%
1%
Yes 88¢No 15¢
3¢
$3,862
$329,944
0.05%
15%
N/A
3mo 3d
active
kalshi

Above 6000

53%
Yes 53¢No 48¢
1¢
N/A
$267,172
0.23%
4%
$78,639
3mo 2d
active
polymarket

↑6k

42%
1%
Yes 43¢No 59¢
2¢
$1,062
$7,080
19%
N/A
N/A
3mo 3d
active
PredictionHero
Market Consensus
47.5%
Yes 48¢No 53.5¢
Avg: 1.5¢Max: 2¢
kalshi

Above 8000

16%
4%
Yes 17¢No 84¢
1¢
N/A
$150,992
0.07%
3%
$50,238
3mo 2d
active
polymarket

↑7.5k

14%
1%
Yes 15¢No 86¢
1¢
$2,323
$197,865
0.05%
0.99%
N/A
3mo 3d
active
kalshi

Above 10000

7%
Yes 8¢No 93¢
1¢
N/A
$161,814
0%
0.14%
$53,196
3mo 2d
active
polymarket

↑10k

6%
Yes 6.5¢No 94.1¢
0.6¢
$9,151
$6,527,380
0%
0.01%
N/A
3mo 3d
active
PredictionHero
Market Consensus
6.5%
Yes 7.3¢No 93.6¢
Avg: 0.8¢Max: 1¢
polymarket

↑12.5k

2%
Yes 2.8¢No 98.7¢
1.5¢
$1,785
$357,202
0%
0%
N/A
3mo 3d
active
polymarket

↑500

100%
Yes 100¢No 0.1¢
0.1¢
N/A
$102,618
N/A
N/A
N/A
3mo 2d
Yes
kalshi

Above 500

99%
Yes 100¢No 0¢
100¢
N/A
$24,148
N/A
N/A
$5,394
3mo 2d
No
polymarket

↑1k

100%
Yes 100¢No 0.1¢
0.1¢
N/A
$72,146
N/A
N/A
N/A
3mo 2d
Yes
polymarket

↑2k

100%
Yes 100¢No 0.1¢
0.1¢
N/A
$51,003
N/A
N/A
N/A
3mo 2d
Yes
kalshi

Above 2000

99%
Yes 100¢No 100¢
100¢
N/A
$95,929
N/A
N/A
$34,701
3mo 2d
Yes
polymarket

↑3.5k

100%
Yes 100¢No 0.1¢
0.1¢
N/A
$15,825
N/A
N/A
N/A
3mo 3d
Yes
kalshi

Above 750

99%
Yes 100¢No 0¢
100¢
N/A
$49,281
N/A
N/A
$2,859
3mo 2d
No
kalshi

Above 1000

99%
Yes 100¢No 0¢
100¢
N/A
$30,706
N/A
N/A
$8,205
3mo 2d
No
kalshi

Above 1500

99%
Yes 100¢No 1¢
1¢
N/A
$19,699
N/A
N/A
$4,047
3mo 2d
Yes
kalshi

Above 1750

99%
Yes 100¢No 1¢
1¢
N/A
$18,108
N/A
N/A
$6,240
3mo 2d
Yes
kalshi

Above 1250

99%
Yes 100¢No 0¢
100¢
N/A
$16,430
N/A
N/A
$6,853
3mo 2d
No
Total markets: 25

Description

These markets collectively assess whether measles cases in the U.S. during 2026 will exceed various thresholds (500 to 12,500 confirmed cases). Resolution depends entirely on CDC's official measles case counter, which serves as the authoritative source for all platforms. The markets form a ladder structure, allowing traders to express granular views on outbreak severity.

PredictionHero - Resolution Divergence Alerts (RDA)

Divergence Detected

Issue: Polymarket uses strict 'at least' thresholds (500, 1000, 2000, 3000, 4000, 5000, 7500, 10000, 12500 cases), while Kalshi uses 'above' thresholds (500, 750, 1000, 1250, 1500, 1750 cases) with different granularity and one incomplete market definition.Hero tip: If you trade on both platforms, note that Polymarket's thresholds are fixed at round numbers while Kalshi's are more granular in the lower range. Kalshi's incomplete market (threshold missing) creates ambiguity—clarify the missing threshold before trading. The 'at least' vs 'above' distinction matters at exact boundary values (e.g., exactly 1000 cases resolves YES on Polymarket but NO on Kalshi).

Critical divergence points:

  • Polymarket: Uses 'at least' resolution logic with 9 distinct thresholds: 500, 1000, 2000, 3000, 4000, 5000, 7500, 10000, and 12500 confirmed measles cases. Resolution source is the CDC Measles (Rubeola) counter between January 1 and December 31, 2026. Quote: 'This market will resolve to Yes if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter.'
  • Kalshi: Uses 'above' resolution logic with 6 defined thresholds (500, 750, 1000, 1250, 1500, 1750 cases) and one incomplete market with a missing threshold value. Quote: 'If the number of measles in 2026 is above [threshold], then the market resolves to Yes.' The seventh market definition is incomplete and unresolvable as written.
Our PredictionHero Resolution Divergence Alerts (RDA) are there to help users identify potential differences across platforms. They do not replace or supersede the official rules and description of any prediction market. Users are solely responsible for reviewing and understanding the applicable rules and resolution criteria before placing any trade or bet. If you notice a potential inconsistency, discrepancy, or error in an alert, please report it to our team so we can review and improve the accuracy of our data.

Polymarket

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.

Kalshi

The market resolves to Yes based on the total number of measles cases reported in 2026 exceeding specified thresholds. Resolution depends on official case counts from relevant public health authorities, with separate outcomes for case totals above 1500, 1750, 2000, 3000, 4000, 6000, 8000, and 10000.

Frequently asked questions

On Polymarket and Kalshi, this dashboard tracks the consensus view on the number of measles cases expected in the U.S. during 2026. Currently, the aggregate volume across both platforms is $9,406,849, with $2,140 traded in the last 24 hours. The Polymarket currently favors Will there be at least 4000 measles cases in the U.S. in 2026? at 98.2%, while Kalshi leans toward Will there be more than 3000 measles cases in 2026? at 99.0%. This allows traders to express their beliefs about potential outbreaks and public health responses, creating a forward-looking indicator. The short_topic, the 2026 measles cases market, provides a focused view on this specific prediction.

Prediction market odds often reflect a 'wisdom of the crowd' effect, potentially incorporating more diverse information than traditional analyst forecasts. While analyst predictions for measles cases in 2026 are available from organizations like the CDC and WHO, this market provides a real-time, aggregated assessment based on financial incentives. Discrepancies between this market and analyst forecasts could highlight differing assumptions about vaccination rates, outbreak containment measures, or the emergence of new strains. It’s important to note that prediction markets are probabilistic, representing the likelihood of various outcomes, whereas analyst forecasts may present single-point estimates.

Prices on Polymarket and Kalshi can diverge due to several factors. Polymarket and Kalshi can show different implied probabilities for the same outcome because of liquidity, fee structure, participant mix, and how each venue defines the contract. Each platform has a different user base, trading fees, and liquidity, which can influence price discovery. Additionally, the specific contracts offered on each platform—Will there be at least 4000 measles cases in the U.S. in 2026? and Will there be more than 3000 measles cases in 2026?—define different outcomes, leading to varied probabilities. For example, one platform might focus on whether cases exceed a specific threshold, while the other asks about a broader range. Differences in trading volume and the timing of information flow can also contribute to price discrepancies, even for the same underlying event.

This market resolves around Jan 1, 2027, with the outcome confirmed once the event is verifiable from credible public reporting. The final number of reported measles cases in the U.S. during 2026, as documented by a recognized public health authority like the CDC, will determine the outcome. Traders will be able to see the final result and how it aligns with their predictions. The resolution process aims to provide a transparent and objective assessment of the market's accuracy, based on publicly available data.

Several factors could significantly impact this market. Major outbreaks of measles in densely populated areas, changes in vaccination policies at the state or federal level, and the emergence of vaccine-resistant strains are all potential catalysts. News regarding the effectiveness of current measles vaccines or the development of new ones could also shift trader sentiment. Public health campaigns aimed at increasing vaccination rates, or conversely, anti-vaccination movements gaining traction, would be closely watched. Any significant announcements from the CDC or WHO regarding measles trends would likely cause movement in this market.